CSNews

Phillip Morris International Requests Continued Modified-Risk Claim for IQOS

SILVER SPRING, Md. — Philip Morris International Inc. (PMI) made its case to continue to market its heat-not-burn IQOS as a ...

PMI Urges FDA To Renew IQOS MRTP Status, Citing Strong Evidence Of Reduced Harm And Switching

Philip Morris International Inc. (PM) announced that it recently presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC), a panel of independent ...
Agence France-Presse

Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific ...
Pittsburgh Steelers

Cheat Sheet: Week 4 vs. Vikings

The Steelers defeated Minnesota in the first ever meeting in 1962, but the Vikings won the next three matchups. Of the first 13 times these teams met between 1962 and 1995, Minnesota won eight, but ...
ascopubs.org

Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or ...

Germline Pathogenic/Likely Pathogenic Mutations and Subsequent Neoplasms Among Childhood Cancer Survivors: A Report From the Children's Oncology Group ALTE03N1 Study Patients received escalating ...
C&EN

Three-Pronged Approach (Active Pharmaceutical Ingredients, Excipients, and NOx-Free Air) Successfully Suppressed the Formation of Nitroso-atomoxetine to 0.097 ppm

API Business Division, New Materials Department, Osaka Plant, Towa Pharmaceutical Co., Ltd., 3-8 Matsuo-cho, Kadoma, Osaka 571-0044, Japan ...